 |
Tongalp H. Tezel, M.D."Patients should receive the utmost care, which includes an up-to-date clinical knowledge, accurate and individualized clinical decision making and perfect surgical skills. I believe the combination of these with honesty and respect is a guarantee for professional success and satisfaction." To Schedule an Appointment with Dr. Tezel, Call (502) 852-5466 or (502) 852-766 |
Dr. Tezel's main clinical interest is focused on the surgical and medical treatment of vitreoretinal diseases. Vitreous is the gel that fills the center of the eye and attaches firmly to the retina which is the light-sensitive inner lining of the eye. Retina converts the light into nerve signals and sends them along the optic nerve to the brain where these signals are decoded to form visual perception. Diseases affecting the retina and vitreous manifest themselves with significant visual problems since disorders of the retina do not allow the eye to communicate with the brain. Some examples of such diseases include age-related macular degeneration, diabetic retinopathy, macular holes, epiretinal membranes, retinal detachment, vein occlusions and ocular tumors. Treatment of these disorders may include the use of lasers and surgical means, as well as application of certain medications. Several clinical trials have formed the scientific basis for treatment guidelines and outcome expectations for each of these disorders. Dr. Tezel's clinical practice involves the most updated medical and surgical care for these diseases combined with an individualized treatment plan for his patients.
Dr. Tezel has been intensely involved in cutting-edge retinal research including the development of retinal transplantation techniques and innovative treatment modalities for age-related macular degeneration. His laboratory is currently focused on investigating the molecular mechanisms of various retinal diseases using advanced experimental techniques, such as proteomic analysis.
Current Position
Associate Professor, Department of Ophthalmology and Visual Sciences, Department of Anatomical Sciences and Neurobiology; Director of, Fellowship Program in Vitreoretinal Diseases and Surgery
Specialties
Surgical and Medical Treatment of Vitreoretinal Diseases
Board Certification
Turkish Board of Ophthalmology - 1989
American Board of Ophthalmology- 2003
Medical License
Kentucky
Indiana
New York
Contact Information
Research Website
Laboratory of Tongalp H. Tezel, MD
Education
Hacettepe University Medical School, 1978-1984
Hacettepe University Hospitals, Ankara, Turkey, Internship, 1983-84
Department of Ophthalmology, Ankara Numune Hospital, Ankara, Turkey, Residency, 1986-1989
Department of Ophthalmology, Rigshospitalet Copenhagen University School of Medicine, Copenhagen, Denmark, Clinical Fellowship in Vitreoretinal Surgery, 1993-1994
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, Fellowship in Vitreoretinal Research, 1994-1997
Department of Internal Medicine, St. Mary's Health Center, St. Louis, Missouri, Internship, 1998-1999
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, Residency in Ophthalmology, 1999-1902
College of Physicians and Surgeons of Columbia University, Department of Ophthalmology, New York, NY, Clinical Fellowship in Vitreoretinal Surgery, 2002-2003
Professional Societies and Affiliations
American Academy of Ophthalmology
Association for Research in Vision and Ophthalmology
International Society for Eye Research
American Medical Association
Macula Society
Retina Society
American Society of Retina Specialists
Select Publications
Tezel TH, Del Priore LV, Kaplan HJ. Re-engineering of aged Bruch's membrane to enhance retinal pigment epithelium repopulation. A new model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2004; 45:3337-3348.
Tezel TH, Bora N, Kaplan, HJ. Pathogenesis of Age-related Macular Degeneration. Trends in Mol Med, 2004; 10(9):417-420.
Tezel TH, Del Priore LV: Reattachment to a substrate prevents apoptosis of human retinal pigment epithelium. Graefe's Arch Clin Exp Ophthalmol 1997;235:41-47.
Tezel TH, Kaplan HJ, Del Priore LV. Posterior vitreous detachment with Dispase. Retina 1998;18:7-15.
Tezel TH, Del Priore LV, Kaplan HJ. Fate of human retinal pigment epithelial cells seeded onto layers of Bruch's membrane. Invest Ophthalmol Vis Sci 1999;40:467-76.
Tezel TH, Kaplan HJ. Are intravitreal anti-VEGF antibodies safe? Ocul
Immunol Inflamm, 2007; 15:1-2
Tezel TH. Intraocular pharmacotheraphy: specificity and safety issues.
Expert Rev Ophthalmol, 2007;2:671-675.
Tezel TH, Del Priore LV, Berger A, Kaplan HJ. Adult retinal pigment
epithelium transplantation in exudative age-related macular degeneration. Am
J Ophthalmol, 2007; 143: 584-595.
Tezel TH. Detection of subclinical exudative AMD with a clinical
challenge Test. Retina Today November/December 2007;33-38
Tezel TH, Kaplan HJ. Are intravitreal anti-VEGF antibodies safe? Ocul Immunol Inflamm, 2007; 15:1-2
Tezel TH. Intraocular pharmacotheraphy: specificity and safety issues. Expert Rev Ophthalmol, 2007;2:671-675.
Tezel TH, Del Priore LV, Berger A, Kaplan HJ. Adult retinal pigment epithelium transplantation in exudative age-related macular degeneration. Am J Ophthalmol, 2007; 143: 584-595.